Drugs-Generic Industry

Below are the top drugs-generic stocks on the NASDAQ in terms of PEG ratio. Superior Industries International Inc. (NYSE: SUP) has a PEG ratio of 0.33. Superior Industries' trailing-twelve-month EPS is $0.69. Sagent Pharmaceuticals Inc (NASDAQ: SGNT) has a PEG ratio of 0.78. Sagent...

Below are the top drugs-generic stocks on the NASDAQ in terms of EPS growth forecast for the next five years. Evoke Pharma Inc (NASDAQ: EVOK) earnings per share growth forecast for the next five years is 40.00 percent. Evoke Pharma has a market capitalization of $33.54 million. Steadymed Ltd (...

Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Adamas Pharmaceuticals (NASDAQ: ADMS) is 333.80%. Adamas Pharma's revenue for the same period is $71.10 million. The trailing-twelve-month return on equity at Versartis...

Below are the top mid-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Akorn (NASDAQ: AKRX) is 13.00%. Akorn's EPS for the same period is $0.46. The trailing-twelve-month return on assets at Salix Pharmaceuticals (...

Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Akorn (NASDAQ: AKRX) is 20.78%. Akorn's revenue for the same period is $304.28 million. The trailing-twelve-month return on equity at Salix Pharmaceuticals (NASDAQ:...

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Akorn (NASDAQ: AKRX) is 27.84%. Akorn's PEG ratio is 2.02. The trailing-twelve-month operating margin at Salix Pharmaceuticals (NASDAQ: SLXP) is 26.47%....

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Akorn (NASDAQ: AKRX) is 14.50%. Akorn's PEG ratio is 1.23. The trailing-twelve-month return on assets at Hi-Tech Pharmacal Co (NASDAQ: HITK) is 7.81%. Hi-...

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash. Salix Pharmaceuticals (NASDAQ: SLXP) had $817.98 million in total cash and $875.74 million in total debt for the latest quarter. Mylan (NASDAQ: MYL) had $360.07 million in total cash for the latest quarter....

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of PEG ratio. Salix Pharmaceuticals (NASDAQ: SLXP) has a PEG ratio of 0.98. Salix's trailing-twelve-month operating margin is 25.74%. Akorn (NASDAQ: AKRX) has a PEG ratio of 1.08. Akorn had $45.86 million in total cash for...

Below are the top drugs-generic stocks on the NASDAQ in terms of cash. Salix Pharmaceuticals (NASDAQ: SLXP) had $751.01 million in total cash for the latest quarter. However, Salix had $857.26 million in total debt for the same period. Mylan (NASDAQ: MYL) had $409.54 million in total cash and $5....

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Hi Tech Pharmacal Co (NASDAQ: HITK) is 15.77%. Hi Tech Pharmacal's ROE for the same period is 15.20%. The trailing-twelve-month profit margin at Akorn (NASDAQ:...

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash. Salix Pharmaceuticals (NASDAQ: SLXP) had $775.90 million in total cash and $869.10 million in total debt for the latest quarter. Mylan (NASDAQ: MYL) had $412.67 million in total cash for the latest quarter....

Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Akorn (NASDAQ: AKRX) is 18.99%. Akorn's revenue for the same period is $227.26 million. The trailing-twelve-month return on equity at Hi Tech Pharmacal Co (NASDAQ: HITK...

Below are the top small-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Hi Tech Pharmacal Co (NASDAQ: HITK) is 17.45%. Hi Tech Pharmacal's revenue for the same period is $230.00 million. The trailing-twelve-month...

Below are the top drugs-generic stocks on the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Mylan (NASDAQ: MYL) is $6.39 billion. Mylan's ROA for the same period is 5.89%. The trailing-twelve-month revenue at Salix Pharmaceuticals Ltd (NASDAQ: SLXP) is $605.72 million. Salix...